Pixium hires new CEO and director

Pixium has appointed Khalid Ishaque as CEO and director. Previously, Ishaque worked at Boston Scientific where he most recently served as general manager of its neuromodulation international business. Based in Paris, Pixium is a maker of vision restoration systems for the blind. Its backers include Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Bpifrance, Seventure and Polytechnos.

Gecko Biomedical raises Series A

Medical device company Gecko Biomedical has closed a 8 million euros ($11 million) Series A financing round. The financing was co-led by Omnes Capital and CM-CIC Capital Finance, and joined by CapDecisif Management.

Pixium Vision raises funds led by Sofinnova

Pixium Vision, a developer of innovative retinal implant systems, has closed a Series A extension financing. This round was led by Sofinnova Partners, with support from Bpifrance, through the InnoBio fund, and existing series A investors Omnes Capital and Abingworth. In conjunction with the financing, Antoine Papiernik at Sofinnova Partners and Chahra Louafi at Bpifrance have joined the Pixium board of directors.

Scality Lands $22 Million, Led by Menlo Ventures and Iris Capital

Scality, a San Francisco-based startup that is focused on large-scale storage management, has closed on $22 million in Series C funding, bringing its total capital raised to $35 million. Menlo Ventures and Iris Capital led the round, which included participation from FSN PME and existing investors Idinvest Partners, OMNES Capital, and Galileo Partners.

Poxel Appoints Khoso Baluch to Board

Biopharma startup Poxel has appointed Khoso Baluch to its board of directors. Baluch will serve as an independent director. He is senior vice president & president European region at UCB, the global biopharmaceutical company. Poxel is backed by Edmond de Rothschild Investment Partners, InnoBio and Omnes Capital.

EyeTechCare Raises $13M From Chauvin, Omnes, SHAM

French company EyeTechCare SA said it raised a $13 million third round of funding from private investor Bernard Chauvin as well as existing investors Omnes Capital (formerly Credit Agricole Private Equity) and the Lyon-based insurer SHAM. The company is developing medical devices for the ophthalmology market.

EyeTechCare Raises Third Round of Funding

French company EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market has secured a third round of funding amounting to ten million euros ($13 million). Bernard Chauvin, a private investor, has taken an equity stake in the company alongside Omnes Capital (formerly Credit Agricole Private Equity) and the Lyon-based insurer SHAM.

Medisse Closes Series B

Medisse has closed a Series B equity financing round for the clinical trial of its lead product FlexiSurge(R) Adhesion Barrier. New investor IIG has joined the existing investors, BioGeneration Ventures and Omnes Capital in the round. Medisse is active in resorbable implants for soft tissue applications, based on a patented flexible polymer platform.

PEHUB Community

Join the 12494 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget